Research Monitor - March Quarter 2017 Research16 Jan 2017

The Australian Share Market, as measured by the S&P/ASX300 Index, rose by 4.0% on a price basis and 4.9% on an accumulation basis during the December Quarter, mirroring the gains of the previous quarter.


The key feature of the quarter was the surprise market behaviour around the US Presidential Election. Most market commentators had figured that a Clinton victory would be good for markets and a Trump victory would be bad, based mostly on an assessment of known versus unknown. The expectation of a pick-up in government spending in the United States, a higher level of economic growth, rising inflation and therefore higher interest rates is being built into share prices.


At a sector level, Banks and Insurance stocks were the belles of the ball, up 13.8% and 16.0% inclusive of dividends for the quarter. The Capital Goods and Utility sectors also performed well, up 10.9% and 9.2% respectively, including dividends. In fact, all of the returns of the market for the December quarter were from six stocks. CBA, WBC, BHP, ANZ, NAB and QBE. The remainder of all other stocks in the ASX300 comprised zero returns when combined together.


Analysis of the top performers from a market perspective in the December quarter shows that a “bar-bell” approach of holding banks and resources stocks performed particularly well.


Moving in the other direction were the Health Care and Pharmaceutical sectors which both retreated over 8% for the quarter. CSL was amongst the worst performers, down 6.8%, alongside Ramsay Healthcare (RHC) down 14.6%. The move in the 10 year bond rate from 1.91% to 2.70% over the quarter kept pressure on Infrastructure stocks with Transurban (TCL) down 9.8% and Sydney Airport (SYD) down 14.4%


Read the full report

Related Articles
Research01 May 2020 Research Monitor - June Quarter 2020 Edition
INSIDE THIS ISSUE Q1 2020 Performance: The advent of the new coronavirus outbreak is one of those events often referred to as “Black Swans”. Banks and dividends: The bad debt c... Read More
Research20 Jan 2020 Research Monitor - March Quarter 2020 Edition
INSIDE THIS ISSUE: Q4 2019 Performance. Investors who avoided the banks and stuck with the pharma sector would have handsomely outperformed the index. 2020 Outlook for ASX200. ... Read More
Research17 Oct 2019 Research Monitor - December Quarter 2019 Edition
INSIDE THIS ISSUE Q3 2019 Performance. There were once again some spectacular returns amongst small companies. Investing in a low interest rate environment. Investors need to f... Read More
Research05 Jul 2019 Research Monitor - September Quarter 2019 Edition
  INSIDE THIS ISSUE Is the Australian economy turning the corner? Overall, with lower interest rates, tax cuts and an improving fiscal picture, the Australian economy is set ... Read More
A - Z  % Change  
{{data.Symbol}} {{data.CompanyName}} {{data.Close}} {{data.AsAt | date :'shortTime'}} {{data.Movement | number : 2}} {{data.MovementPercent | number: 2}}%